Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Scott Kopetz, Jayesh Desai, Emily Chan, Joel Randolph Hecht, Peter J O'Dwyer, Dipen Maru, Morris Van, Filip Janku, Arvind Dasari, Woonbook Chung, Jean-Pierre J Issa, Peter Gibbs, Brian James, Garth Powis, Keith B Nolop, Suman Bhattacharya, Leonard Saltz
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2015
Awarded by National Cancer Institute
Awarded by National Institutes of Health Cancer Center Support
Awarded by NATIONAL CANCER INSTITUTE
Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Supported by Plexxikon and Roche. The correlative work was supported in part by the National Institutes of Health Cancer Center Support Grant No. CA16670 to The University of Texas MD Anderson Cancer Center. The authors acknowledge support from the National Cancer Institute under Awards No. R01CA172670 (S.K., G.P.), R01 CA160398 (G.P.), and R01CA184843 (S.K.).